Medicover AB (FRA:5M0B) Cyclically Adjusted Revenue per Share: €10.12 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5M0B Medicover AB FRA:5M0B
91 GF Score
Price €20.55
GF Value €20.54
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Cyclically Adjusted Revenue per Share?

Medicover AB FRA:5M0B +2.24% 91 Cyclically Adjusted Revenue per Share is €10.12 as of Jun. 2026. GuruFocus rates FRA:5M0B with a GF Score™ of 91/100 and a GF Value™ of €20.54 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medicover AB's adjusted revenue per share for the three months ended in Jun. 2026 was €4.214. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €10.12 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Medicover AB's average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-01), Medicover AB's current stock price is €20.55. Medicover AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €10.12. Medicover AB's Cyclically Adjusted PS Ratio of today is 2.03.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Medicover AB was 2.77. The lowest was 1.71. And the median was 2.05.


Medicover AB  (FRA:5M0B) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medicover AB's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=20.55/10.12
=2.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Medicover AB was 2.77. The lowest was 1.71. And the median was 2.05.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medicover AB Cyclically Adjusted Revenue per Share Related Terms


Medicover AB Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medicover AB's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Cyclically Adjusted Revenue per Share Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 9.74

Medicover AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.28 9.33 9.74 9.82 10.12

FRA:5M0B vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Medicover AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medicover AB's Cyclically Adjusted PS Ratio falls into.


FRA:5M0B
91GF Score
Medicover AB FRA:5M0B
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicover AB Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicover AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.214/134.6100*134.6100
=4.214

Current CPI (Jun. 2026) = 134.6100.

Medicover AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.284 101.138 1.709
201612 1.382 102.022 1.823
201703 1.064 102.022 1.404
201706 1.259 102.752 1.649
201709 1.080 103.279 1.408
201712 1.136 103.793 1.473
201803 1.214 103.962 1.572
201806 1.208 104.875 1.551
201809 1.255 105.679 1.599
201812 1.359 105.912 1.727
201903 1.498 105.886 1.904
201906 1.522 106.742 1.919
201909 1.591 107.214 1.998
201912 1.723 107.766 2.152
202003 1.791 106.563 2.262
202006 1.453 107.498 1.819
202009 1.769 107.635 2.212
202012 2.006 108.296 2.493
202103 2.138 108.360 2.656
202106 2.352 108.928 2.907
202109 2.258 110.338 2.755
202112 2.537 112.486 3.036
202203 2.573 114.825 3.016
202206 2.432 118.384 2.765
202209 2.475 122.296 2.724
202212 2.670 126.365 2.844
202303 2.802 127.042 2.969
202306 2.838 129.407 2.952
202309 2.943 130.224 3.042
202312 3.086 131.912 3.149
202403 3.317 132.205 3.377
202406 3.393 132.716 3.441
202409 3.515 132.304 3.576
202412 3.702 132.987 3.747
202503 3.829 132.825 3.880
202506 3.952 133.699 3.979
202509 3.918 133.480 3.951
202512 4.052 133.390 4.089
202603 4.107 133.560 4.139
202606 4.214 134.610 4.214

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €10.12 mean?
Medicover AB (FRA:5M0B) has a Cyclically Adjusted Revenue per Share of €10.12 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medicover AB and its competitors.
Is Medicover AB's Cyclically Adjusted Revenue per Share too high?
Medicover AB's current Cyclically Adjusted Revenue per Share is €10.12. Overall, Medicover AB has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Medicover AB's Cyclically Adjusted Revenue per Share of €10.12 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medicover AB and its competitors. Medicover AB's current Cyclically Adjusted Revenue per Share is €10.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (FRA:5M0B) is currently considered Fairly Valued. The stock's GF Value™ is €20.54, compared to a current price of €20.55 — trading 0% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €10.12. Medicover AB's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medicover AB (FRA:5M0B), the current Cyclically Adjusted Revenue per Share is €10.12 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (FRA:5M0B) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of €20.55 is trading 0% above its estimated GF Value™ of €20.54. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for FRA:5M0B:

  • Cyclically Adjusted Revenue per Share: €10.12
  • GF Value™: €20.54 vs. price of €20.55 (0% above fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the FRA:5M0B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
91GF Score

Get the complete analysis for FRA:5M0B

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.55
Price
€20.54
GF Value